Food and Drug Law Journal 2024 Symposium
From Past to Progress: Envisioning the Future of FDA Law and Regulation
November 13, 2024 | In-Person & Virtual Event
Preliminary Agenda
Subject to Change
All Times Are Eastern Standard Time
Thursday, November 13
FDLI Welcome and Opening Remarks
9:30–9:45 AM
Paige Samson, Interim Director, Educational Programs and Director, Innovative Programs and Publications, FDLI
Cynthia L. Meyer, Partner, Kleinfeld, Kaplan & Becker, LLP and Chair, FDLJ Editorial Advisory Board
“How Courts Reviewed FDA Action Before Chevron and May Again After Loper Bright”
Paper Presentation and Discussion | Abstract
9:45–11:00 AM
Authors: Eva F. Yin, Partner; Daniel Orr, Senior Counsel; and Jonathan Trinh, Associate, Wilson Sonsini Goodrich & Rosati
Break
11:00–11:20 AM
“Defective by Design: A Historical Overview of FDA’s Food Defect Regulations”
Paper Presentation and Discussion | Abstract
11:20 AM–12:35 PM
Author: Liam Hospidales, JD Candidate, Wake Forest University School of Law
Lunch Break
12:35–1:50 PM
“The Challenges of Regulating Information as Medicine”
Paper Presentation and Discussion | Abstract
1:50 PM–3:05 PM
Authors: Barbara J. Evans, Professor of Law and Stephen C. O’Connell Chair,
University of Florida Levin College of Law; Azra Bihorac, Senior Associate Dean
for Research, University of Florida; and Eric S. Rosenthal, Associate Professor of Neurology, Harvard Medical School
Break
3:05–3:25 PM
Arnold & Porter LLP AI Survey Overview and Panel Discussion
3:25 PM–4:25 PM
Daniel A. Kracov, Partner, Arnold & Porter LLP
Reception (In-Person Only)
4:25–6:00 PM